RWM
TECH icon

Ritholtz Wealth Management’s Bio-Techne TECH Stock Holding History

Ritholtz Wealth Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,824
Closed -$272K – 724
2022
Q3 		$272K Buy
+3,824
New +$330K 0.01% 571
2021
Q4 		– Sell
-2,020
Closed -$245K – 585
2021
Q3 		$245K Buy
+2,020
New +$246K 0.02% 425

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Ritholtz Wealth Management's TECH Position: Q4 2022 in Review

Ritholtz Wealth Management sold out of Bio-Techne (TECH) in Q4 2022, closing a stake of 3,824 shares — an estimated $272K sold.

Ritholtz Wealth Management first reported a position in TECH in Q3 2021 and held it in 2 quarters. The position peaked at $272K in Q3 2022. 545 funds tracked by Wall St. Rank hold TECH as of Q4 2022.

  • Ritholtz Wealth Management reported no remaining Bio-Techne position as of Q4 2022 after selling out during the quarter.
  • Ritholtz Wealth Management sold 3,824 Bio-Techne shares in Q4 2022, an estimated $272K.
  • Ritholtz Wealth Management first reported a position in Bio-Techne in Q3 2021 and held it in 2 quarters.
  • Ritholtz Wealth Management's Bio-Techne position peaked at $272K in Q3 2022.
  • 545 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2022.

Based on Ritholtz Wealth Management's 13F filing for Q4 2022, filed 19 Jan 2023.